SEC Form 4 · accession 0001193125-26-256002
CORCEPT THERAPEUTICS INC · CORT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gary Charles Robb
Officer — Chief Business Officer
Period of report
Jun 1, 2026
Accepted (ET)
Jun 3, 2026 · 7:15 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001088856
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2,F3 | Jun 1, 2026 | A | 776 | $70.44 | A | 25,263 | D | |
| Common StockF4,F3 | Jun 1, 2026 | A | 776 | $0.00 | A | 26,039 | D | |
| Common StockF6,F7 | Jun 2, 2026 | F | 358 | $70.44 | D | 25,681 | D | |
| Common StockF8 | holding | — | — | — | 12,571 | I | Custodial Account for Child | |
| Common StockF9 | holding | — | — | — | 12,571 | I | Custodial Account for Child | |
| Common StockF10 | holding | — | — | — | 49,716 | I | Gary Charles Robb TTE Robb Revocable Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The Reporting Person purchased shares ("Purchase Plan Shares") of the Issuer's common stock pursuant to a purchase plan ("Purchase Plan") established under the Corcept Therapeutics Incorporated 2024 Incentive Award Plan on June 1, 2026.
- F10These shares are held by Gary Charles Robb TTE Robb Revocable Trust of which the Reporting Person is trustee.
- F2In accordance with the Purchase Plan, the price was established based on the closing price on the day of the purchase.
- F3Includes 997 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 2, 2025, 251 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025, 224 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, and 499 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements.
- F4Shares underlie unvested restricted stock awards granted to the Reporting Person by the Issuer under the Purchase Plan. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person remains the beneficial owner of the Purchase Plan Shares through such one-year anniversary.
- F5These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units.
- F6The closing price on June 1, 2026 was used to calculate the withholding obligation.
- F7Includes 251 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025, 224 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, and 499 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements.
- F8These shares are held by a child of the Reporting Person through a custodial account under the Uniform Transfers to Minors Act for which the Reporting Person is custodian.
- F9These shares are held by a child of the Reporting Person through a custodial account under the Uniform Transfers to Minors Act for which the Reporting Person is custodian.
Remarks
The power of attorney under which this form was signed is on file with the Commission.